Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioharvest Sciences (BHST) Shares Outstanding (Weighted Average) (2023 - 2025)

Bioharvest Sciences has reported Shares Outstanding (Weighted Average) over the past 3 years, most recently at $18.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 13.69% year-over-year to $18.4 million; the TTM value through Dec 2025 reached $18.4 million, up 13.69%, while the annual FY2025 figure was $18.4 million, 13.69% up from the prior year.
  • Shares Outstanding (Weighted Average) was $18.4 million for Q4 2025 at Bioharvest Sciences, up from $17.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $97.6 million in Q3 2024 and bottomed at $400.0 in Q3 2023.
  • The 3-year median for Shares Outstanding (Weighted Average) is $17.3 million (2025), against an average of $23.8 million.
  • Year-over-year, Shares Outstanding (Weighted Average) soared 24400150.0% in 2024 and then crashed 82.15% in 2025.
  • Over 3 years, Shares Outstanding (Weighted Average) stood at $13.5 million in 2023, then rose by 19.66% to $16.2 million in 2024, then increased by 13.69% to $18.4 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $18.4 million (Q4 2025), $17.4 million (Q3 2025), and $17.3 million (Q2 2025) per Business Quant data.